3 Hidden Gem Stocks Under $35

Lower-priced stocks are often considered diamonds in the rough or higher-risk bets, and there is some truth to this. They may not be the safest options or for the faint of heart. Yet lower-priced stocks can be excellent drivers of growth in a portfolio, even (perhaps especially) in the most uncertain of times.

A note from our sponsors...

Yet what separates the best from the rest? Our Zen Ratings system will be your guide. A-rated stocks have an average annual return of +32.52%, well above the market average. And with that in mind, here are 3 stocks under $35 with an A-rating that are worth your attention.

1. Veracyte Inc (NASDAQ: VCYT)

A biotech company specializing in diagnostics, VCYT is still making strides in cancer diagnosis and treatment, and there’s little need for me to explain the profit potential in such an endeavor. In a previous video on this stock, we noted it was on a good trajectory. 

While it has experienced a slight downturn from late last year, it is still in a good position overall compared to this time last year, has a strong forecast from analysts (+31.12% average), and has a Component Grade of A for Growth, signaling that VCYT still has room to move and possibly be a nice treatment for your portfolio.

Now on to the other 2 stocks…

2. Mntn Inc (NYSE: MNTN)

An app industry stock currently hovering around $10 a share, MNTN takes the advertising world in a new direction with more targeted options that allow even small businesses to advertise on TV using a connected TV advertising platform.

In the marketing world, more direct results and targeting will be key to success, and MNTN may just be one of the apps that drive the industry forward, moving beyond the standard placements and TV spots most of us were used to for so long. That in itself makes the stock worth watching.

However, it’s also helpful to know it has a Zen Rating of A with Component Grades of A for both Financials and Sentiment. This means key players are enthused about the stock, and it has a solid financial base to work from. While this doesn’t guarantee safety (no one can guarantee the safety of any stock), it looks better than many peers.

3. Electromed Inc (NYSEMKT: ELMD)

While not strictly having the best last few months, ELMD is still on a relatively strong year, and it’s strong by the fundamentals. Specializing in airway clearance therapy for bronchiectasis, it’s important to note that almost a million people have been diagnosed with the disease, and many more people remain undiagnosed. Essentially: There’s a potentially strong market.

It’s also a smaller company with tons of room to grow, making it a potentially great option. Its debt-to-equity ratio is stellar, and it has a Component Grade of A for Sentiment, Safety, and Financials. It is, for the most part, a stock focused heavily on a single product, but it is promising, and the company is tackling the business relatively safely.

If you’re looking for more information on any of the above stocks (or others), then WallStreetZen Premium is what you need. With it, you’ll get all the fundamental information you need, an unlimited watchlist, access to premium Stock Ideas pages, and more.

Yet what if you want a more guided approach during uncertain times? Then you’ll want Zen Investor. With it, you will gain access to regular webinars and commentary from our own Steve Reitmeister, who has more than 40 years of investing experience. You’ll also receive access to a model portfolio hand-picked by him using his experience, combined with the Zen Ratings system.

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.